These symptoms were found to be to occur more frequently and have an earlier presentation in Groups 2 and 3 when compared to Group 1. Furthermore, the severity of symptoms in Groups 2 and 3 were much worse than Group 1. Survival was worse in Group 3 which had the highest mortality rate (30% of patients) and the shortest median survival period of 4.9 years. Group 1, on the other hand, exhibited the best survival with a mortality rate of 8% and a median survival period of 7.3 years. Survival for Group 2 fell between Group 1 and 3. Similarly, disease progression occurred in a higher percentage of the patients in Group 3 (58% of patients) than those in Group 2 (31%) or Group 1 …show more content…
Although more research is warranted to validate this assumption, specialized dietary recommendations to help manage the adverse effects of antineoplastic treatments could soon become a new standard of care for cancer patients. This would create a need for more registered dietitians to provide this type of individualized nutritional therapy for this population. Nutrition may never be a first-line therapy for treating cancer, but it holds the potential for improving the response to radiation and chemotherapy as well as long-term survival and quality of